Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Hartlapp

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Beitrage Zu Infusionstherapie Und Klinische Ernahrung|January 1, 1983
[Preventive administration of immunoglobulins in bronchial carcinoma patients treated with aggressive chemotherapy]R E Schmidt, M Lüttkenhorst, J H Hartlapp, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 1, 1987
[Therapeutic results in small-cell bronchial carcinoma after ACO II chemotherapy and adjuvant radiation]N Leipner, T Harder, B Hövelmann, et al.
Infection|May 1, 1984
Reduction of infection frequency by intravenous gammaglobulins during intensive induction therapy for small cell carcinoma of the lungR E Schmidt, J H Hartlapp, D Niese, et al.
Klinische Wochenschrift|June 1, 1989
Multiple nodular foci in the liver associated with chronic hepatic porphyria after previous treatment of breast cancerW K Lelbach, T R Müller, W Kersjes, et al.
Klinische Wochenschrift|November 15, 1985
Alternatives to CYVADIC-combination therapy of soft tissue sarcomasJ H Hartlapp, H J Münch, H J Illiger, et al.
Onkologie|September 28, 2001
Palliation by intratumoral infiltration with natural interferon-betaE Musch, M Malek, G Lammering, et al.
European Journal of Clinical Pharmacology|January 1, 1988
The pharmacokinetics of melphalan during intermittent therapy of multiple myelomaU Loos, E Musch, M Engel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Alternatives to CYVADIC combination therapy of soft tissue sarcomasJ H Hartlapp, H J Münch, H J Illiger, et al.
Strahlentherapie|April 1, 1982
[Whole-body irradiation in case of malignant lymphomas of low malignancy (author's transl)]L Labedzki, R E Schmidt, J H Hartlapp, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Beitrage Zu Infusionstherapie Und Klinische Ernahrung|January 1, 1983
[Preventive administration of immunoglobulins in bronchial carcinoma patients treated with aggressive chemotherapy]R E Schmidt, M Lüttkenhorst, J H Hartlapp, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 1, 1987
[Therapeutic results in small-cell bronchial carcinoma after ACO II chemotherapy and adjuvant radiation]N Leipner, T Harder, B Hövelmann, et al.
Infection|May 1, 1984
Reduction of infection frequency by intravenous gammaglobulins during intensive induction therapy for small cell carcinoma of the lungR E Schmidt, J H Hartlapp, D Niese, et al.
Klinische Wochenschrift|June 1, 1989
Multiple nodular foci in the liver associated with chronic hepatic porphyria after previous treatment of breast cancerW K Lelbach, T R Müller, W Kersjes, et al.
Klinische Wochenschrift|November 15, 1985
Alternatives to CYVADIC-combination therapy of soft tissue sarcomasJ H Hartlapp, H J Münch, H J Illiger, et al.
Onkologie|September 28, 2001
Palliation by intratumoral infiltration with natural interferon-betaE Musch, M Malek, G Lammering, et al.
European Journal of Clinical Pharmacology|January 1, 1988
The pharmacokinetics of melphalan during intermittent therapy of multiple myelomaU Loos, E Musch, M Engel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Alternatives to CYVADIC combination therapy of soft tissue sarcomasJ H Hartlapp, H J Münch, H J Illiger, et al.
Strahlentherapie|April 1, 1982
[Whole-body irradiation in case of malignant lymphomas of low malignancy (author's transl)]L Labedzki, R E Schmidt, J H Hartlapp, et al.
Pageof 4